QUANTERIX
Quanterix Corporation is developing a novel platform for single-molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. The companyโs ultra-sensitive detection solution, Simoa, ... has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterixโs technology is designed to enable much earlier disease detection, better prognosis, and precise treatment methods to improve the quality of life and longevity of the population for generations to come.
QUANTERIX
Industry:
Biotechnology Health Care Health Diagnostics Life Science Pharmaceutical
Founded:
2007-01-01
Address:
Billerica, Massachusetts, United States
Country:
United States
Website Url:
http://www.quanterix.com
Total Employee:
251+
Status:
Active
Contact:
617-301-9400
Email Addresses:
[email protected]
Total Funding:
533.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Quantum SI
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-06-26 | UmanDiagnostics | UmanDiagnostics acquired by Quanterix | 22.5 M USD |
Investors List
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation investment in Grant - Quanterix
T. Rowe Price
T. Rowe Price investment in Series D - Quanterix
Hercules Capital
Hercules Capital investment in Series D - Quanterix
ARCH Venture Partners
ARCH Venture Partners investment in Series D - Quanterix
ARCH Overage Fund
ARCH Overage Fund investment in Series D - Quanterix
Tufts University
Tufts University investment in Series D - Quanterix
Bain Capital Ventures
Bain Capital Ventures investment in Series D - Quanterix
Cormorant Asset Management
Cormorant Asset Management investment in Series D - Quanterix
Trinitas Capital
Trinitas Capital investment in Series D - Quanterix
bioMerieux
bioMerieux investment in Series C - Quanterix
Key Employee Changes
Date | New article |
---|---|
2020-11-19 | Quanterix appoints chief operating officer |
Official Site Inspections
http://www.quanterix.com Semrush global rank: 241.55 K Semrush visits lastest month: 291.99 K
- Host name: ec2-34-199-95-206.compute-1.amazonaws.com
- IP address: 34.199.95.206
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149